[1]周颖丽,罗 茜,尹紫薇,等.郭志华治疗高脂血症临床经验[J].陕西中医,2023,(6):781-784.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
　ZHOU Yingli,LUO Xi,YIN Ziwei,et al.Guo Zhihua's clinical experience in the treatment of hyperlipidemia[J].,2023,(6):781-784.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
点击复制

郭志华治疗高脂血症临床经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年6期
页码:
781-784
栏目:
名中医经验
出版日期:
2023-06-05

文章信息/Info

Title:
Guo Zhihua's clinical experience in the treatment of hyperlipidemia
作者:
周颖丽1; 2; 罗 茜1; 2; 尹紫薇1; 2; 郑惠珍1; 2; 王子焱1; 刘承鑫1; 郭志华1
(1.湖南中医药大学,湖南 长沙 410208; 2.湖南中医药大学第一附属医院,湖南 长沙 410011)
Author(s):
ZHOU Yingli; LUO Xi; YIN Ziwei; ZHENG Huizhen; WANG Ziyan; LIU Chengxin; GUO Zhihua
(Hunan University of Chinese Medicine,Changsha 410208,China)
关键词:
高脂血症;  痰浊;  化浊方;  脾;  肾
Keywords:
Hyperlipidemia;  Phlegmatic-turbidity;  Huazhuo prescription;  Spleen;  Kidney
分类号:
R 589.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.06.023
文献标志码:
A
摘要:
文章介绍郭志华老师对高脂血症的中医病名、病因病机的认识,总结郭志华老师治疗高脂血症的临床诊疗思路和用药经验,并列举一则验案加以佐证。郭志华老师基于多年临床经验,认为高脂血症属中医“痰浊”范畴,其基本病机为脾虚不能运化,肾虚气化不利,水谷精微失输,膏脂生化失常,痰浊凝积经脉。故结合病名及病机认识,郭志华老师以健脾益气,补肾祛湿为高脂血症治疗原则,以补肾健脾为主,兼以降脂化浊之法,并自拟化浊方治疗高脂血症,预防心血管疾病。郭志华老师结合临床上高脂血症与心脑血管疾病联系紧密的特点,注重兼病论治,对兼有胸痹、心悸、眩晕等病的患者,随病化裁,精准用药,在临床上卓有成效。
Abstract:
This paper introduces Guo Zhihua's understanding of the traditional Chinese medicine disease name,etiology and pathogenesis of hyperlipidemia,and summarizes the clinical diagnosis and treatment ideas and experience of Guo Zhihua in the treatment of hyperlipidemia,and lists an empirical case to prove it.Based on many years of clinical experience,Guo Zhihua believes that hyperlipidemia belongs to the category of “phlegm-turbidity” in traditional Chinese medicine,and its basic pathogenesis is spleen deficiency,adverse kidney deficiency and gasification,fine loss of water and grain,biochemical disorders of oil and fat,phlegm-turbidity and accumulation of meridia.Therefore,in combination with the name and pathogenesis of the disease,Guo Zhihua took the principle of strengthening the spleen and invigorating qi,tonifying the kidney and dispelling dampness as the treatment of hyperlipidemia.He mainly used the method of tonifying the kidney and spleen,and also used the method of reducing blood fat and transforming turbidity.He also designed Huazhuo prescription to treat hyperlipidemia and prevent cardiovascular diseases.Considering the close connection between clinical hyperlipidemia and cerebrovascular diseases,Guo Zhihua pays attention to the treatment of concurrent diseases.For patients with chest pain,heart palpitations,vertigo and other diseases,he applies targeted medicine according to the disease,which is clinically effective.

参考文献/References:

[1] 中华医学会心血管病学分会,中国康复医学会心脏预防与康复专业委员会,中国老年学和老年医学会心脏专业委员会,等.中国心血管病一级预防指南[J].中华心血管病杂志,2020,48(12):1000-1038.
[2] 苏 萍,陈 影,张广平,等.阿托伐他汀的肝毒性机制研究[J].药物评价研究,2019,42(11):2174-2179.
[3] 郭向东,陈海潮,杨 征,等.丹红注射液对动脉粥样硬化兔主动脉血红素氧合酶-1表达的影响研究[J].陕西医学杂志,2018,47(12):1522-1524.
[4] 安建峰,孙 烨,刘季元.化瘀调脂方对高脂血症大鼠降脂作用的实验研究[J].陕西中医,2020,41(4):440-442.
[5] 宁素云,滕 丹,慕杨娜,等.基于肠道微生态研究山楂粉调节高脂膳食小鼠血脂的机制[J].中成药,2020,42(11):3062-3069.
[6] 顾思浩,孔维崧,张 彤,等.白术的化学成分与药理作用及复方临床应用进展[J].中华中医药学刊,2020,38(1):69-73.
[7] 魏 晴,匡海学,王秋红.生麦芽和炒麦芽对高脂血症大鼠的降血脂作用研究[J],2018,45(7):1538-1542.
[8] 滕力庆,周 涛,王 晓,等.太子参化学成分及其药理作用研究进展[J].食品与药品,2021,23(1):73-79.
[9] 李 涛,宋洪波,安凤平,等.紫山药抗性淀粉调节高脂血症金黄地鼠脂质代谢[J].中国食品学报,2021,21(3):95-101.
[10] 朱柏雨,杨 程,姜媛媛,等.中药六神曲消化酶和生物活性研究进展[J].分子植物育种,2018,16(11):3763-3767.
[11] 张叶茁,杨岳峰,杨野仝,等.茯苓复合提取物对2型糖尿病大鼠血糖和血脂水平的影响[J].吉林大学学报:医学版,2020,46(5):937-941.
[12] 程婷婷,原新博,惠小涵,等.荷叶生物碱成分及其调脂机制研究进展[J].中草药,2019,50(8):1998-2003.
[13] 李陈雪,杨玉赫,冷德生,等.枳壳化学成分及药理作用研究进展[J].辽宁中医药大学学报,2019,21(2):158-161.
[14] 钟方为,李庚喜,曾 立.基于肠道菌群和短链脂肪酸代谢探讨绞股蓝总皂苷改善大鼠非酒精性脂肪肝病的实验研究[J].中国中药杂志,2022,47(9):2500-2508.
[15] 匡 琳,李 卉,魏佳明,等.郭志华从“心脑相关”理论治疗眩晕临床经验_匡琳[J].中医药临床杂志,2022,34(1):57-60.
[16] 罗 莉,黄浩洋,李玉莹,等.郭志华从“阴火”论治心悸[J].中医药临床杂志,2021,33(2):258-260.
[17] 娄序笙,庞兴学,陈步星.高龄女性射血分数保留的心力衰竭患者相关危险因素分析[J].中华老年心脑血管病杂志,2022,24(11):1153-1155.
[18] 成 明,李 慧.高血压高脂血症患者血清TC、TG水平及WBC的相关性及其对预后评估的价值[J].川北医学院学报,2021,36(6):798-801.
[19] 魏 挺,庄 稼,刘 江,等.辛伐他汀联合复方丹参滴丸对高脂血症患者血脂和脂质比值的影响[J].陕西医学杂志,2016,45(9):1228-1230.
[20] 吴巧敏,刘金凤,汪艳丽,等.刘如秀教授论治血浊经验[J].陕西中医,2022,43(5):624-627.
[21] 郑飞飞,刘 岩,于志强.于志强从“郁滞论”辨治高脂血症经验[J].湖北中医杂志,2021,43(9):26-29.
[22] 俞 操,沈祥峰,薛宇辉,等.程志清教授从脏腑气化论治高脂血症临床经验荟萃[J].浙江中医药大学学报,2021,45(7):739-743.
[23] 夏 翼,刘 丹.阿昔莫司联合非诺贝特治疗高脂血症的临床效果[J].河北医药,2022,44(3):433-435.
[24] 谭冬梅,李 彬,何成伟,等.温胆汤合大承气汤治疗高脂血症急性胰腺炎(湿热中阻证)的疗效观察[J].中国中医急症,2022,31(4):663-666.
[25] 李丽飞,向 茜.高脂血症性胰腺炎的治疗进展[J].吉林医学,2022,43(5):1396-1399.
[26] 陈晓旭,徐琳萍.理脾清脂汤对冠心病伴高脂血症患者的应用价值[J].山东医学高等专科学校学报,2022,44(5):377-380.

相似文献/References:

[1]丁 维,钟立仁,张海波,等.丹参酮ⅡA磺酸钠对高脂血症勃起功能障碍大鼠Nrf2/HO-1通路及勃起功能的影响*[J].陕西中医,2020,(11):1520.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.002]
　DING Wei,ZHONG Liren,ZHANG Haibo,et al.Sodium tanshinone ⅡA sulfonate ameliorates erectile function in hyperlipidemia ED rats by up-regulating Nrf2/HO-1[J].,2020,(6):1520.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.002]
[2]潘赐明,朱培超,SISHIR Sharma,等.齿痕舌源流考及临床意义探讨[J].陕西中医,2021,(9):1267.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.031]
[3]刘小微,李娟娥,姜小帆,等.丹蒌片对载脂蛋白E基因敲除小鼠血脂及AMPK/SREBP通路的影响[J].陕西中医,2021,(11):1531.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.008]
[4]孙帅玲,马晓北.基于网络药理学探讨茵陈蒿汤治疗高脂血症作用机制[J].陕西中医,2021,(12):1793.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.038]
[5]吴巧敏,刘金凤,汪艳丽,等.刘如秀教授论治血浊经验[J].陕西中医,2022,(5):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
　WU Qiaomin,LIU Jinfeng,WANG Yanli,et al.Professor LIU Ruxiu's experience in treating hyperlipidemia[J].,2022,(6):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
[6]黄稚真,胡 敏,梁惠卿,等.化痰祛瘀法治疗肝豆状核变性研究进展[J].陕西中医,2023,(6):815.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.030]
　HUANG Zhizhen,HU Min,LIANG Huiqing,et al.Research advance in the treatment of hepatolenticular degeneration by dispelling phlegm and removing stasis[J].,2023,(6):815.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.030]
[7]周 芳,陈文明,陈新宇,等.冬春谧阳方对高脂血症患者PPARγ/ANGPTL受体配体的影响[J].陕西中医,2023,(11):1537.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.009]
　ZHOU Fang,CHEN Wenming,CHEN Xinyu,et al.Effect of Dongchun Miyang decoction on serum PPARγ/ANGPTL receptor ligand in patients with hyperlipidemia[J].,2023,(6):1537.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.009]
[8]周 艳,王 顺,白 妍.从肝论治帕金森病非运动症状[J].陕西中医,2024,(2):230.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.018]
　ZHOU Yan,WANG Shun,BAI Yan.Treatment non-motor symptoms of Parkinson 's disease from liver[J].,2024,(6):230.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.018]
[9]郑佳雯,冯子芹,郑 瑀,等.因虚致郁论治灼口综合征[J].陕西中医,2024,(2):239.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.020]
　ZHENG Jiawen,FENG Ziqin,ZHENG Yu,et al.Treatment of burning mouth syndrome due to the theory of deficiency causing depression[J].,2024,(6):239.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.020]
[10]鲁志林,陈继东,周广文,等.名中医向楠补肾化痰方治疗绝经后骨质疏松症经验[J].陕西中医,2024,(5):687.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.026]
　LU Zhilin,CHEN Jidong,ZHOU Guangwen,et al.Professor XIANG Nan's experience in treating postmenopausal osteoporosis with Bushen Huatan prescription[J].,2024,(6):687.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.026]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82174343); 湖南省重点研发计划项目(2022SK2012); 湖南中医药大学中医学一流学科开放基金资助项目(2022ZYX12)
更新日期/Last Update: 2023-06-09